Science & Enterprise subscription

Follow us on Twitter

  • A smartphone app is collecting individual reports about Covid-19 symptoms and other health conditions to provide ea… https://t.co/gxdMGhThvO
    about 15 hours ago
  • New post on Science and Enterprise: Phone App Tracking Covid-19 Symptom Reports https://t.co/67W6hKYsQe #Science #Business
    about 15 hours ago
  • A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license… https://t.co/R1SLXtUQXg
    about 20 hours ago
  • New post on Science and Enterprise: Start-Up Licenses Immunotherapies in $880M Deal https://t.co/udtVXhqw7K #Science #Business
    about 20 hours ago
  • CRISPR pioneer Doudna opens lab to run Covid-19 tests ... Also Broad Inst. ... https://t.co/7QGSFzgJfP via @statnews
    about 23 hours ago

Please share Science & Enterprise

Start-Up Licenses Immunotherapies in $880M Deal

Human T-cell

A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal

Biotechs Explore Cell Therapy for Covid-19 Antibodies

Coronavirus face mask

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Sanofi, Biotech Partner on RNA Covid-19 Vaccine

SARS-Cov-2 virus

Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine

Consortium to Find Neutralizing Viral Antibodies

Human B-cell

A coalition of business and academic labs is creating a process to quickly identify antibodies in blood samples that neutralize viruses like SARS-CoV-2. . . . → Read More: Consortium to Find Neutralizing Viral Antibodies

Venture Fund to Back Covid-19 Start-Ups

Caspr Biotech

A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups

Trial to Test Arthritis Drug for Covid-19 Pneumonia

Human lungs illustration

A clinical trial is beginning soon that tests a current drug for rheumatoid arthritis as a treatment for severe pneumonia in patients with Covid-19 infections. . . . → Read More: Trial to Test Arthritis Drug for Covid-19 Pneumonia

Engineered Blood Cells Created for Cancer Therapies

Macrophage

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies

New Venture Formed to Discover Neuro Therapies

Brain hemispheres graphic

Two drug discovery companies are forming a joint venture to discover treatments for neurological conditions based on cannabinoid-like compounds. . . . → Read More: New Venture Formed to Discover Neuro Therapies

WHO Beginning Covid-19 Therapy Trial

Tedros Adhanom Ghebreyesus

World Health Organization is organizing an international clinical trial to test four treatments for the novel coronavirus, or Covid-19, pandemic. . . . → Read More: WHO Beginning Covid-19 Therapy Trial

FDA Outlines Trial Disruption Steps Due to Covid-19

Coronavirus face mask

The Food and Drug Administration outlined steps clinical trial teams should take if their studies face disruptions from the novel coronavirus, or Covid-19, pandemic. . . . → Read More: FDA Outlines Trial Disruption Steps Due to Covid-19